Mesylate PCR Master Mix for Forensic Inhibitor Mitigation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

PCR inhibitors present in forensic samples, such as blood, fabrics, and soil, interfere with nucleic acid amplification during polymerase chain reaction (PCR), leading to incomplete or failed amplifications, which hampers forensic genetic analysis.

Innovation Solution

A PCR master mix comprising a mesylate, such as potassium methanesulfonate, Tris-mesylate, bovine serum albumin, glycerol, deoxynucleoside triphosphates, and a DNA polymerase, which is used in conjunction with a thermal cycling protocol and electrophoretic separation to enhance nucleic acid amplification and overcome inhibitor effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional PCR master mix is used, then the amplification process is simple and straightforward, but PCR inhibitors in forensic samples interfere with nucleic acid amplification leading to incomplete or failed amplifications

Engineering Contradiction:
Improveamplification success rateVSAvoidmaster mix composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces mesylate compounds as intermediary substances in the PCR master mix that mediate between the PCR inhibitors present in forensic samples and the DNA polymerase reaction. The mesylate acts as a protective agent that neutralizes or reduces the inhibitory effects of contaminants in blood, fabrics, soil and other forensic materials, thereby enabling successful amplification without requiring complex sample purification steps

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite PCR master mix formulation that combines traditional PCR components (buffer, dNTPs, primers, polymerase) with mesylate compounds. This composite formulation integrates multiple functional elements into a single reagent system that simultaneously maintains optimal PCR conditions while providing protection against a broad spectrum of PCR inhibitors through the mesylate component

Inventive Principle:
Principle #40Composite materials

2Reliability

If sample purification steps are added to remove inhibitors, then amplification success improves, but the process time and complexity increase

Engineering Contradiction:
Improveamplification success rateVSAvoidtotal analysis time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The mesylate compounds are incorporated into the PCR master mix in advance, performing the protective function against inhibitors before the actual PCR amplification begins. This preliminary incorporation eliminates the need for separate post-purification steps, as the protection is already in place when the reaction starts

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent merges the inhibitor protection function with the PCR amplification reagents by incorporating mesylate compounds directly into the master mix. This combination consolidates multiple functions (buffer maintenance, nucleotide provision, enzyme protection, and inhibitor neutralization) into a single integrated reagent system, eliminating separate purification steps

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of the mesylate-containing PCR master mix significantly improves the amplification of nucleic acids by mitigating the inhibitory effects of PCR inhibitors, resulting in increased resolution of amplicons and improved forensic analysis outcomes.

Implementation Method 1

a DNA polymerase

Methodology Applied
Scientific EffectDNA polymerization: Enzyme

Implementation Method 2

electrophoretic separation

Methodology Applied
Scientific EffectElectrophoresis: Electrophoresis

Implementation Method 3

thermal cycling protocol

Methodology Applied
Scientific EffectThermal denaturation: Melting

Data Source

PatentUS11293059B2Mesylate based master mix
Publication Date: 2022.04.05 LIFE TECHNOLOGIES CORP
  • US11293059B2 patent drawing
  • US11293059B2 patent drawing
  • US11293059B2 patent drawing

AI summary

Disclosed herein are mesylate containing compositions, methods of use of such compositions and kits of components encompassing such compositions for improving the amplification of nucleic acids, especially in the presence of enzymatic inhibitors. These find particular use in forensic and environmental analyses. The instant disclosure provides new compositions, methods and kits of components for overcoming PCR inhibition. In some embodiments disclosed herein is a PCR master mix, the PCR master mix encompassing a mesylate.